Journal
CHEMICAL SCIENCE
Volume 4, Issue 11, Pages 4137-4145Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c3sc51902c
Keywords
-
Categories
Funding
- Life Sciences Institute at the University of Michigan
- Department of Chemistry at the University of Michigan
- College of Pharmacy at the University of Michigan
- University of Kentucky
- Alzheimer's Art Quilt Initiative (AAQI)
- Ruth K. Broad Medical Foundation
- Alfred P. Sloan Foundation
- Research Excellence Fellowship from the Department of Chemistry at the University of Michigan
Ask authors/readers for more resources
The number of people suffering from Alzheimer's disease (AD) is expected to increase dramatically in the coming decades. Currently, acetylcholinesterase inhibitors (AChEis) provide some relief of cognitive symptoms, while newer approaches, such as amyloid-beta (A beta)-targeted metal chelation, offer potential hope for slowing and/or reversing disease progression. This work details the synthesis and biochemical evaluation of a novel hybrid of 6-chlorotacrine and a metal-A beta modulator that chemically combines an AChEi and an A beta-targeted metal chelator into a single molecule. This hybrid shows potent inhibition of AChE under various conditions, interaction with Cu2+ and Zn2+, control of metal-free and metal-induced A beta aggregate assembly, and disaggregation of preformed metal-free and metal-associated A beta aggregates. As such, the hybrid described herein represents a promising, new multifunctional compound for AD studies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available